Emerging prospects of vitamin D3 in metabolic syndrome: A proof of concept (POC) approach targeting inflammation

Authors

  • Yogendra Singh Mahatma Gandhi College of Pharmaceutical Sciences, Sitapura, Jaipur, India
  • Gaurav Gupta School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India. E-mail: gauravpharma25@gmail.com
  • Ritu M. Gilhotra School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India
  • Sachin Kumar Singh School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India
  • Parteek Prasher Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, India
  • Anand Krishnan Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences and National Health Laboratory Service, University of the Free State, Bloemfontein, South Africa
  • Kamal Dua Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia
  • Dinesh Kumar Chellappan Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia

DOI:

https://doi.org/10.17179/excli2020-2964

Keywords:

metabolic syndrome, vitamin D, cardiovascular disease

Published

2020-11-09

How to Cite

Singh , Y. ., Gupta, G., Gilhotra, R. M., Singh, S. K., Prasher, P. ., Krishnan , A. ., … Chellappan, D. K. . (2020). Emerging prospects of vitamin D3 in metabolic syndrome: A proof of concept (POC) approach targeting inflammation. EXCLI Journal, 19, 1512–1516. https://doi.org/10.17179/excli2020-2964

Issue

Section

Letters to the editor

Most read articles by the same author(s)

1 2 3 > >>